Catalyst Pharmaceuticals, Inc. (CPRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 940.39M | 894.03M | 852.45M | 758.74M | 685.72M | 623.61M | 539M | 474.43M | 404.6M | 219.33M | 192.02M | 240.97M |
| Cash & Short-Term Investments | 755.86M | 709.17M | 689.89M | 652.8M | 580.66M | 517.55M | 442.33M | 375.69M | 310.41M | 137.64M | 120.97M | 178.79M |
| Cash Only | 755.86M | 709.17M | 689.89M | 652.8M | 580.66M | 517.55M | 442.33M | 375.69M | 310.41M | 137.64M | 120.97M | 178.79M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 131.31M | 128.27M | 106.77M | 66.31M | 72.26M | 65.49M | 58.27M | 57.28M | 60.64M | 53.65M | 48.05M | 42.8M |
| Days Sales Outstanding | 78.19 | 70.84 | 53.65 | 43.02 | 43.83 | 40.14 | 41.3 | 43.72 | 52.79 | 42.31 | 40.69 | 34.82 |
| Inventory | 34.93M | 37.17M | 28.03M | 18.65M | 19.78M | 19.54M | 20.02M | 18.01M | 19.95M | 15.64M | 9.04M | 10.75M |
| Days Inventory Outstanding | 134.18 | 115.02 | 84.83 | 58.36 | 98.79 | 84.08 | 90.75 | 112.14 | 129.37 | 71.81 | 64.24 | 79.63 |
| Other Current Assets | 2.72M | 2.04M | 3.53M | 1.24M | 452K | 1.03M | 509K | 1.03M | 0 | 351K | 352K | 361K |
| Total Non-Current Assets | 207.22M | 212.78M | 199.15M | 213.18M | 223.15M | 227.8M | 233.01M | 231.93M | 242.07M | 250.78M | 221.19M | 202.93M |
| Property, Plant & Equipment | 2.85M | 2.97M | 3.09M | 3.23M | 3.4M | 3.58M | 3.68M | 3.6M | 3.75M | 3.7M | 3.76M | 3.84M |
| Fixed Asset Turnover | 51.30x | 50.38x | 46.96x | 44.21x | 40.52x | 39.04x | 35.36x | 33.41x | 26.44x | 29.63x | 27.01x | 25.42x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 121.97M | 131.67M | 128.64M | 137.98M | 147.33M | 156.67M | 166.02M | 175.36M | 184.71M | 194.05M | 167.11M | 175.59M |
| Long-Term Investments | 27.29M | 22.54M | 19.17M | 21.26M | 24.21M | 21.56M | 14.84M | 13.08M | 15.35M | 16.49M | 12.9M | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1.15B | 1.11B | 1.05B | 971.91M | 908.87M | 851.41M | 772.01M | 706.36M | 646.68M | 470.11M | 413.21M | 443.9M |
| Asset Turnover | 0.13x | 0.14x | 0.15x | 0.16x | 0.16x | 0.17x | 0.17x | 0.18x | 0.18x | 0.25x | 0.24x | 0.23x |
| Asset Growth % | 26.27% | 30% | 36.22% | 37.59% | 40.55% | 81.11% | 86.83% | 59.13% | 58.8% | 25.15% | 24.04% | 66.06% |
| Total Current Liabilities | 132.4M | 147.15M | 128.74M | 113.01M | 111.65M | 120.68M | 105.39M | 92.32M | 79.57M | 76.06M | 57.81M | 52.5M |
| Accounts Payable | 7.15M | 11.2M | 9.1M | 5.53M | 11.2M | 16.59M | 11.56M | 7.12M | 10.26M | 14.79M | 4.6M | 4.42M |
| Days Payables Outstanding | 34.16 | 35.81 | 26.58 | 25.4 | 69.82 | 59.84 | 44.57 | 51.32 | 91.06 | 56.43 | 29.28 | 29.51 |
| Short-Term Debt | 446K | 437K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 98.65M | 122.76M | 11.41M | 10.18M | 8.83M | 11.16M | 8.46M | 7.67M | 5.48M | 9.35M | 5.65M | 4.8M |
| Current Ratio | 7.10x | 6.08x | 6.62x | 6.71x | 6.14x | 5.17x | 5.11x | 5.14x | 5.09x | 2.88x | 3.32x | 4.59x |
| Quick Ratio | 6.84x | 5.82x | 6.40x | 6.55x | 5.96x | 5.01x | 4.92x | 4.94x | 4.83x | 2.68x | 3.17x | 4.38x |
| Cash Conversion Cycle | 178.22 | 150.05 | 111.91 | 75.98 | 72.8 | 64.37 | 87.48 | 104.54 | 91.1 | 57.69 | 75.66 | 84.93 |
| Total Non-Current Liabilities | 2.52M | 5.39M | 2.62M | 2.88M | 2.94M | 3.1M | 5.67M | 5.39M | 5.7M | 6.17M | 6.86M | 16.1M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 2.23M | 2.35M | 2.46M | 2.57M | 2.68M | 2.79M | 2.89M | 2.99M | 3.09M | 3.19M | 3.28M | 3.38M |
| Deferred Tax Liabilities | 0 | 2.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 280K | 209K | 161K | 309K | 259K | 315K | 2.79M | 2.4M | 2.61M | 2.98M | 3.58M | 12.72M |
| Total Liabilities | 134.91M | 152.54M | 131.36M | 115.89M | 114.59M | 123.78M | 111.07M | 97.7M | 85.26M | 82.23M | 64.66M | 68.6M |
| Total Debt | 2.68M | 2.79M | 2.89M | 2.99M | 3.09M | 3.19M | 3.28M | 3.38M | 3.47M | 3.56M | 3.64M | 3.73M |
| Net Debt | -753.18M | -706.38M | -687M | -649.81M | -577.57M | -514.37M | -439.05M | -372.32M | -306.94M | -134.08M | -117.33M | -175.06M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | 0.03x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.06x | 0.05x | 0.09x | 0.07x | - | 0.07x |
| Net Debt / EBITDA | -9.07x | -9.90x | -9.08x | -8.58x | -7.93x | -7.11x | -8.62x | -5.85x | -8.40x | -2.64x | - | -3.17x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | -140.33x | - |
| Total Equity | 1.01B | 954.27M | 920.25M | 856.03M | 794.28M | 727.63M | 660.94M | 608.65M | 561.41M | 387.88M | 348.55M | 375.29M |
| Equity Growth % | 27.5% | 31.15% | 39.23% | 40.64% | 41.48% | 87.59% | 89.63% | 62.18% | 68.26% | 29.11% | 29.07% | 55.66% |
| Book Value per Share | 7.98 | 7.50 | 7.24 | 6.71 | 6.26 | 5.76 | 5.27 | 4.88 | 4.55 | 3.41 | 3.27 | 3.30 |
| Total Shareholders' Equity | 1.01B | 954.27M | 920.25M | 856.03M | 794.28M | 727.63M | 660.94M | 608.65M | 561.41M | 387.88M | 348.55M | 375.29M |
| Common Stock | 122K | 123K | 123K | 122K | 122K | 121K | 119K | 119K | 118K | 107K | 107K | 107K |
| Retained Earnings | 523.35M | 474.19M | 446.79M | 394.01M | 341.9M | 285.16M | 229.22M | 185.34M | 144.55M | 121.27M | 86.43M | 117.19M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 8K | 0 | 0 | 31K | -17K | 64K | 0 | 0 | 0 | 14K | 15K | 19K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |